Saturday, April 04, 2009

Merck's Dick Clark on Big Pharma's “trust deficit”


This from the guy who brought you Vioxx:


Richard Clark, chairman and CEO of Merck & Co., who also serves as chairman of the Pharmaceutical Research and Manufacturers of America, said at that organization's annual meeting here that the industry needs to keep pushing for national health reform, expanding access to medicines for the world's poor and limiting enticements to doctors to help overcome a “trust deficit.”
More

2 comments:

Anonymous said...

Gilmartin brought us Vioxx.

Vagelos was the best CEO Merck has had, and none have come close since his departure in 1994

Medical Quack said...

I saw this too, and thought is this the pot calling the kettle black?

Oh well, guess it is a start of some sort.